Clinical Trial Update: rTMS and Botulinum Toxin in Benign Essential Blepharospasm [NA]

View source ↗

Summary

A completed clinical trial evaluating rTMS and botulinum toxin for Benign Essential Blepharospasm; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Essential Blepharospasm

Drugs mentioned

• Botulinum toxin (botulinum toxin)
• RTMS (Repetitive transcranial magnetic stimulation)

Snippet

Sponsor: University of Florida | Conditions: Benign Essential Blepharospasm | NA | Status: COMPLETED | Results posted: 2023-09-15